Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder

Soares, Claudio N.; Thase, Michael E.; Clayton, Anita; More

Menopause . 17(4):700-711, July 2010.

Menopausal transition, mood, and cognition: an integrated view to close the gaps

Soares, Claudio N.; Maki, Pauline M.

Menopause . 17(4):812-814, July 2010.

Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition

Maki, Pauline M.; Freeman, Ellen W.; Greendale, Gail A.; More

Menopause . 17(4):815-822, July 2010.

Shift in the brain network of emotional regulation in midlife women: is the menopausal transition the turning point?

Frey, Benicio N.; Hall, Geoffrey B.; Attard, Stefanie; More

Menopause . 17(4):840-845, July 2010.

Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms

Joffe, Hadine; Soares, Claudio N.; Thurston, Rebecca C.; More

Menopause . 16(4):671-679, July/August 2009.

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life

Soares, Claudio N.; Arsenio, Helga; Joffe, Hadine; More

Menopause . 13(5):780-786, September/October 2006.

Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles

Thurston, Rebecca C.; Joffe, Hadine; Soares, Claudio N.; More

Menopause . 13(4):553-560, July/August 2006.